Lantern Pharma is trading 10.63% higher at $1.04 on October 6, 2026; no confirmed company-specific catalyst was found. - The latest release listed on the company’s investor-relations page was September 30. - Broader U.S. markets are higher, which may support sentiment, while biotechnology stocks are under pressure and do not explain the gain. - Available evidence does not establish a definitive cause for the sharp move.